Aritz Lafuente
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aritz Lafuente has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Borja Sepúlveda
Instituto de Microelectrónica de Barcelona (IMB-CNM, CSIC), Barcelona, 08193, Spain
3 shared publications - Alejandro Gomez Roca
Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
2 shared publications - Josep Nogues
Catalan Institute of Nanoscience and Nanotechnology (ICN2) CSIC and BIST Barcelona Spain
2 shared publications - Ofra Benny
School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel
2 shared publications - Albert Serrà
Grup d’Electrodeposició de Capes Primes i Nanoestructures (GE-CPN), Departament de Ciència de Materials i Química Física, Universitat de Barcelona, Martí i Franquès, 1, E-08028 Barcelona, Catalonia, Spain
1 shared publication Alejandro G. Roca
Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, 08193 Bellaterra, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 14 (43) , 21054-21065
Exploring the design space of SMART RHESINs as a modular nanocapsule platform for functional magnetic nanoparticles
Fifty-two reactions map a compatibility-dependent SMART RHESIN design space for diverse magnetic payloads in a common, expandable architecture. Selected variants demonstrate multi-colour MPI, co-encapsulation and 18 F surface labelling.
- 12 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 14 (43) , 21054-21065
Open AccessExploring the design space of SMART RHESINs as a modular nanocapsule platform for functional magnetic nanoparticles
Fifty-two reactions map a compatibility-dependent SMART RHESIN design space for diverse magnetic payloads in a common, expandable architecture. Selected variants demonstrate multi-colour MPI, co-encapsulation and 18 F surface labelling.
- Open Access
- 15 May 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 12 (15) , 5855-5871
2D MoS 2 /Cu 2 O on 3D mesoporous silica as visible-NIR nanophotocatalysts for environmental and biomedical applications
A novel photocatalytic platform bridging environmental remediation and biomedical applications, degrading pollutants and generating ROS for photodynamic cancer therapy under low-intensity NIR light.
- 15 May 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 12 (15) , 5855-5871
Open Access2D MoS 2 /Cu 2 O on 3D mesoporous silica as visible-NIR nanophotocatalysts for environmental and biomedical applications
A novel photocatalytic platform bridging environmental remediation and biomedical applications, degrading pollutants and generating ROS for photodynamic cancer therapy under low-intensity NIR light.
- Open Access
- 20 October 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (43) , 50330-50343
Modular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities
Multifunctional drug-loaded polymer-metal nanocapsules have attracted increasing attention in drug delivery due to their multifunctional potential endowed by drug activity and response to physicochemical stimuli. Current chemical synthesis methods of polymer/metal capsules require specific optimization of the different components to produce particles with precise properties, being particularly complex for Janus structures combining polymers and ferromagnetic and highly reactive metals. With the aim to generate tunable synergistic nanotherapeutic actuation with enhanced drug effects, here we demonstrate a versatile hybrid chemical/physical fabrication strategy to incorporate different functional metals with tailored magnetic, optical, or chemical properties on solid drug-loaded polymer nanoparticles. As archetypical examples, we present poly(lactic-co-glycolic acid) (PLGA) nanoparticles (diameters 100-150 nm) loaded with paclitaxel, indocyanine green, or erythromycin that are half-capped by either Fe, Au, or Cu layers, respectively, with application in three biomedical models. The Fe coating on paclitaxel-loaded nanocapsules permitted efficient magnetic enhancement of the cancer spheroid assembly, with 40% reduction of the cross-section area after 24 h, as well as a higher paclitaxel effect. In addition, the Fe-PLGA nanocapsules enabled external contactless manipulation of multicellular cancer spheroids with a speed of 150 μm/s. The Au-coated and indocyanine green-loaded nanocapsules demonstrated theranostic potential and enhanced anticancer activity in vitro and in vivo due to noninvasive fluorescence imaging with long penetration near-infrared (NIR) light and simultaneous photothermal-photodynamic actuation, showing a 3.5-fold reduction in the tumor volume growth with only 5 min of NIR illumination. Finally, the Cu-coated erythromycin-loaded nanocapsules exhibited enhanced antibacterial activity with a 2.5-fold reduction in the MIC50 concentration with respect to the free or encapsulated drug. Altogether, this technology can extend a nearly unlimited combination of metals, polymers, and drugs, thus enabling the integration of magnetic, optical, and electrochemical properties in drug-loaded nanoparticles to externally control and improve a wide range of biomedical applications.
- 20 October 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (43) , 50330-50343
Open AccessModular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities
Multifunctional drug-loaded polymer-metal nanocapsules have attracted increasing attention in drug delivery due to their multifunctional potential endowed by drug activity and response to physicochemical stimuli. Current chemical synthesis methods of polymer/metal capsules require specific optimization of the different components to produce particles with precise properties, being particularly complex for Janus structures combining polymers and ferromagnetic and highly reactive metals. With the aim to generate tunable synergistic nanotherapeutic actuation with enhanced drug effects, here we demonstrate a versatile hybrid chemical/physical fabrication strategy to incorporate different functional metals with tailored magnetic, optical, or chemical properties on solid drug-loaded polymer nanoparticles. As archetypical examples, we present poly(lactic-co-glycolic acid) (PLGA) nanoparticles (diameters 100-150 nm) loaded with paclitaxel, indocyanine green, or erythromycin that are half-capped by either Fe, Au, or Cu layers, respectively, with application in three biomedical models. The Fe coating on paclitaxel-loaded nanocapsules permitted efficient magnetic enhancement of the cancer spheroid assembly, with 40% reduction of the cross-section area after 24 h, as well as a higher paclitaxel effect. In addition, the Fe-PLGA nanocapsules enabled external contactless manipulation of multicellular cancer spheroids with a speed of 150 μm/s. The Au-coated and indocyanine green-loaded nanocapsules demonstrated theranostic potential and enhanced anticancer activity in vitro and in vivo due to noninvasive fluorescence imaging with long penetration near-infrared (NIR) light and simultaneous photothermal-photodynamic actuation, showing a 3.5-fold reduction in the tumor volume growth with only 5 min of NIR illumination. Finally, the Cu-coated erythromycin-loaded nanocapsules exhibited enhanced antibacterial activity with a 2.5-fold reduction in the MIC50 concentration with respect to the free or encapsulated drug. Altogether, this technology can extend a nearly unlimited combination of metals, polymers, and drugs, thus enabling the integration of magnetic, optical, and electrochemical properties in drug-loaded nanoparticles to externally control and improve a wide range of biomedical applications.
- Open Access
- 5 December 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (3) , 1946-1958
Efficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules
- 5 December 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (3) , 1946-1958
Open AccessEfficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules